Human pluripotent stem-cells (HPSCs)—including human embryonic stem-cells and human induced pluripotent stem-cells—are reshaping the landscape of regenerative medicine.1,2 In Parkinson's disease, ...

Creative Biolabs launches expanded iPSC and astrocyte differentiation services to support next‑generation disease modeling and neurobiology research.

China has stunned the global medical community with a revolutionary cure for Type 2 diabetes, offering hope to millions ...

Stem-cell–based therapies aim to change that paradigm by repairing or replacing damaged biological systems. If replicated successfully in larger patient populations, the approach could reduce ...

Pasca Lab specializes in growing three-dimensional organoid models from reprogrammed stem cells, which capture molecular changes during fetal brain-like development. Because the human brain cannot be ...

Despite offering great hope for regenerative medicine, the international scientific community is expressing deep concern ...

Regenerative medicines are headed for people with Parkinson’s disease or severe heart failure — but researchers are concerned about minimal clinical-trial data.

Chinese scientists report the first reversal of type-2 diabetes using stem-cell therapy that rebuilt insulin-producing cells.

In human cells, DNA carries chemical or "epigenetic" marks that decide how genes will be used in different tissues. Yet in a ...

A groundbreaking clinical trial is testing whether specially engineered stem cells can help the brain restore its own dopamine production in people with Parkinson’s disease. Because the condition is ...

A new brain implant trial aims to restore lost dopamine cells in Parkinson’s patients. Researchers are now testing it in ...

The squishy insoles in your favorite pair of sneakers help keep your joints safe from daily wear-and-tear, but over time, that cushioning wears down. The same goes for your cartilage—the fibrous ...